Clinical Trial Update: A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase III trial evaluating the efficacy and safety of a donepezil transdermal patch for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil transdermal patch (donepezil)

Snippet

Sponsor: Icure Pharmaceutical Inc. | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED